David A. Siegel Vera Therapeutics, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 74,500 shares of VERA stock, worth $3.02 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
74,500
Previous 60,400
23.34%
Holding current value
$3.02 Million
Previous $2.6 Million
3.49%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
182Shares Held
54.7MCall Options Held
42.2KPut Options Held
121K-
Avoro Capital Advisors LLC New York, NY4.31MShares$174 Million2.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.62MShares$147 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$135 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$120 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$113 Million5.61% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.09B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...